67 related articles for article (PubMed ID: 20222312)
1. [Diagnostic imaging of lymphomas].
Casasnovas O
Rev Prat; 2010 Jan; 60(1):53-8. PubMed ID: 20222312
[TBL] [Abstract][Full Text] [Related]
2. PET/CT for therapy response assessment in lymphoma.
Hutchings M; Barrington SF
J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
[TBL] [Abstract][Full Text] [Related]
3. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Kasamon YL; Jones RJ; Wahl RL
J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
[TBL] [Abstract][Full Text] [Related]
4. Anatomic and functional imaging in the management of lymphoma.
Al-Nahhas A; Win Z; Al-Sayed Y; Khan S; Singh A; Rubello D; Gishen P
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):251-9. PubMed ID: 17538524
[TBL] [Abstract][Full Text] [Related]
5. Imaging of pediatric lymphomas.
Abramson SJ; Price AP
Radiol Clin North Am; 2008 Mar; 46(2):313-38, ix. PubMed ID: 18619383
[TBL] [Abstract][Full Text] [Related]
6. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
7. Use of PET/CT to evaluate response to therapy in lymphoma.
Zanoni L; Cerci JJ; Fanti S
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):633-47. PubMed ID: 22231583
[TBL] [Abstract][Full Text] [Related]
8. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
9. Quantitative CT analysis for assessing response in lymphoma (Cheson's criteria).
Rahmouni A; Luciani A; Itti E
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S102-6. PubMed ID: 16361124
[TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma.
Lustberg MB; Aras O; Meisenberg BR
Eur J Haematol; 2008 Aug; 81(2):154-6. PubMed ID: 18462255
[TBL] [Abstract][Full Text] [Related]
11. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S
Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666
[TBL] [Abstract][Full Text] [Related]
12. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
Perry C; Herishanu Y; Metzer U; Bairey O; Ruchlemer R; Trejo L; Naparstek E; Sapir EE; Polliack A
Eur J Haematol; 2007 Sep; 79(3):205-9. PubMed ID: 17662066
[TBL] [Abstract][Full Text] [Related]
14. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
15. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Hutchings M; Loft A; Hansen M; Pedersen LM; Berthelsen AK; Keiding S; D'Amore F; Boesen AM; Roemer L; Specht L
Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET in Follicular Lymphoma Management.
Bodet-Milin C; Eugène T; Gastinne T; Frampas E; Le Gouill S; Kraeber-Bodéré F
J Oncol; 2012; 2012():370272. PubMed ID: 22899920
[TBL] [Abstract][Full Text] [Related]
17. Reticuloendothelium malignancy: current role of imaging.
Sebastian S; Lucey BC
Cancer Treat Res; 2008; 143():455-68. PubMed ID: 18619228
[TBL] [Abstract][Full Text] [Related]
18. Role of Positron Emission Tomography with Fludeoxyglucose F 18 in Personalization of Therapy in Patients with Lymphoma.
Mato AR; Goy A
PET Clin; 2012 Jan; 7(1):57-65. PubMed ID: 27157018
[TBL] [Abstract][Full Text] [Related]
19. RECIL versus Lugano for Treatment Response Assessment in FDG-Avid Non-Hodgkin Lymphomas: A Head-to-Head Comparison in 54 Patients.
Berzaczy D; Haug A; Staber PB; Raderer M; Kiesewetter B; Jaeger U; Kornauth C; Simonitsch-Klupp I; Mayerhoefer ME
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861433
[TBL] [Abstract][Full Text] [Related]
20. Surveillance imaging for lymphoma: pros and cons.
Lynch RC; Zelenetz AD; Armitage JO; Carson KR
Am Soc Clin Oncol Educ Book; 2014; ():e388-95. PubMed ID: 24857129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]